Info@ThinkPinkRocks.org

Heavily pretreated patients with epidermal growth factor receptor-mutated non-small-cell lung cancer and central nervous system metastases may benefit from treatment with afatinib, say German researchers.

Read More:
Afatinib active against NSCLC nervous system metastases

Scroll to Top